drugset / Trial / NCT00579475

The Effect of Mifepristone on Uterine Fibroids and Breast Tissue

NCT00579475

Phase 1 Completed 30 enrolled Karolinska Institutet
Non-randomizedParallel-groupQuadruple-blindTreatment

Summary

Uterine fibroids are a benign but common condition among women in reproductive age. It is one of the most common reasons for hysterectomy since it often causes bleeding problems sometimes leading to anemia. Several alternative treatment regimens have been investigated that could replace surgery. The antiprogesterone, mifepristone, is one of the most promising drugs that have been tested. In addition to the inhibiting effect on the growth of uterine fibroids antiprogestins have been proposed to have an antiproliferative effect on breast tissue. The purpose of the present study is to evaluate the effect of mifepristone on the volume of uterine fibroids. The study will also address the effect of mifepristone on the breast tissue

Timeline

Start
2004-11
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mifepristone Small molecule 50 mg